Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiru Wang

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|June 2, 2015
Structure-Guided Design of Group I Selective p21-Activated Kinase InhibitorsJames J Crawford, Wendy Lee, Ignacio Aliagas, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Identification of BRaf-Sparing Amino-Thienopyrimidines with Potent IRE1α Inhibitory ActivityRamsay E Beveridge, Heidi Ackerly Wallweber, Avi Ashkenazi, et al.
Journal of Medicinal Chemistry|August 20, 2016
Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) InhibitorsMark Zak, Po-Wai Yuen, Xiongcai Liu, et al.
Nature Communications|December 15, 2020
Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligandsElena Ferri, Adrien Le Thomas, Heidi Ackerly Wallweber, et al.
Nature Chemical Biology|May 6, 2018
Publisher Correction: A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cellsAaron H Nile, Felipe de Sousa E Melo, Susmith Mukund, et al.
Nature Chemical Biology|April 11, 2018
A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cellsAaron H Nile, Felipe de Sousa E Melo, Susmith Mukund, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)Peter S Dragovich, Guiling Zhao, Timm Baumeister, et al.
Mabs|December 15, 2018
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo propertiesAyse Meric Ovacik, Ji Li, Marie Lemper, et al.
Journal of Medicinal Chemistry|January 21, 2015
Discovery of highly potent, selective, and efficacious small molecule inhibitors of ERK1/2Li Ren, Jonas Grina, David Moreno, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2013
Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitorsXiaozhang Zheng, Timm Baumeister, Alexandre J Buckmelter, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|June 2, 2015
Structure-Guided Design of Group I Selective p21-Activated Kinase InhibitorsJames J Crawford, Wendy Lee, Ignacio Aliagas, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Identification of BRaf-Sparing Amino-Thienopyrimidines with Potent IRE1α Inhibitory ActivityRamsay E Beveridge, Heidi Ackerly Wallweber, Avi Ashkenazi, et al.
Journal of Medicinal Chemistry|August 20, 2016
Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) InhibitorsMark Zak, Po-Wai Yuen, Xiongcai Liu, et al.
Nature Communications|December 15, 2020
Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligandsElena Ferri, Adrien Le Thomas, Heidi Ackerly Wallweber, et al.
Nature Chemical Biology|May 6, 2018
Publisher Correction: A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cellsAaron H Nile, Felipe de Sousa E Melo, Susmith Mukund, et al.
Nature Chemical Biology|April 11, 2018
A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cellsAaron H Nile, Felipe de Sousa E Melo, Susmith Mukund, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)Peter S Dragovich, Guiling Zhao, Timm Baumeister, et al.
Mabs|December 15, 2018
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo propertiesAyse Meric Ovacik, Ji Li, Marie Lemper, et al.
Journal of Medicinal Chemistry|January 21, 2015
Discovery of highly potent, selective, and efficacious small molecule inhibitors of ERK1/2Li Ren, Jonas Grina, David Moreno, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2013
Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitorsXiaozhang Zheng, Timm Baumeister, Alexandre J Buckmelter, et al.
Pageof 10